About Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
Neuberger Berman High Yield Strategies Fund Inc. is a non-diversified, closed-end management investment company. The Fund seeks total return (income plus capital appreciation). The Fund normally invests at least 80% of its total assets in high yield debt securities of the United States and foreign issuers, which include securities that are rated below investment grade by a rating agency or are unrated debt securities determined to be of comparable quality by the Fund's investment manager. The Fund invests in sectors, including cable and satellite television, chemicals, consumer - commercial lease financing, electric-generation, food and drug retailers, gaming, gas distribution, health services, media content, medical products, metals and mining, oil field equipment and services, pharmaceuticals, printing and publishing, software-services, telecom-satellite and theaters and entertainment. Neuberger Berman Management LLC is the investment manager of the Fund.
Industry, Sector and Symbol:
- Industry: Closed End Funds
- Sub-Industry: N/A
- Sector: Closed End Funds
- Symbol: NYSEAMERICAN:NHS
- Previous Symbol: NYSE:NHS
- CUSIP: N/A
- Web: www.nb.com
- Annual Dividend: $0.90
- Dividend Yield: 7.4%
- Trailing EPS: $3.68
- Net Margins: 62.04%
- Return on Equity: 8.32%
- Return on Assets: 5.85%
- Outstanding Shares: 19,540,000
Frequently Asked Questions for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
What is Neuberger Berman High Yield Strateges Fd's stock symbol?
Neuberger Berman High Yield Strateges Fd trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NHS."
How often does Neuberger Berman High Yield Strateges Fd pay dividends? What is the dividend yield for Neuberger Berman High Yield Strateges Fd?
Neuberger Berman High Yield Strateges Fd declared a monthly dividend on Wednesday, November 1st. Shareholders of record on Wednesday, November 15th will be given a dividend of $0.0725 per share on Thursday, November 30th. This represents a $0.87 dividend on an annualized basis and a yield of 7.43%. The ex-dividend date is Tuesday, November 14th. View Neuberger Berman High Yield Strateges Fd's Dividend History.
Who are some of Neuberger Berman High Yield Strateges Fd's key competitors?
Some companies that are related to Neuberger Berman High Yield Strateges Fd include Triangle Capital Corporation (TCAP), PennantPark Floating Rate Capital (PFLT), Clearbridge Energy MLP Total Return Fund (CTR), MFS Charter Income Trust (MCR), Fidus Investment Corporation (FDUS), Carador Income Fund PLC (CIFU), Goldman Sachs MLP Income Opportunities Fund (GMZ), Gladstone Investment Corporation (GAIN), Eagle Point Credit Company (ECC), Medley Capital Corporation (MCC), TICC Capital Corp. (TICC), THL Credit (TCRD), Solar Senior Capital (SUNS), WhiteHorse Finance (WHF), Gladstone Capital Corporation (GLAD), Fifth Street Senior Floating Rate Corp. (OCSI), Oxford Lane Capital Corp. (OXLC) and TriplePoint Venture Growth BDC Corp. (TPVG).
Who are Neuberger Berman High Yield Strateges Fd's key executives?
Neuberger Berman High Yield Strateges Fd's management team includes the folowing people:
- Jack L. Rivkin, President, Trustee (Age 77)
- Robert John Conti, Chief Executive Officer (Age 61)
- John M. McGovern, Principal Financial Officer, Principal Accounting Officer, Treasurer (Age 47)
- Chamaine Williams, Chief Compliance Officer (Age 46)
- Brian J. Gaffney, Vice President (Age 58)
- Frederic B. Soule, Vice President (Age 63)
- Michael J. Bradler, Assistant Treasurer (Age 40)
- Frank Rosato, Assistant Treasurer (Age 46)
- Andrew B. Allard, Anti-Money Laundering Compliance Officer (Age 56)
- Maxine L. Gerson, Chief Legal Officer (Age 64)
Who owns Neuberger Berman High Yield Strateges Fd stock?
Neuberger Berman High Yield Strateges Fd's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Wells Fargo & Company MN (3.07%), Advisors Asset Management Inc. (2.76%), Wedbush Securities Inc. (0.00%) and Advisor Group Inc. (0.11%). Company insiders that own Neuberger Berman High Yield Strateges Fd stock include Bradley Tank and Thomas P Oreilly. View Institutional Ownership Trends for Neuberger Berman High Yield Strateges Fd.
Who sold Neuberger Berman High Yield Strateges Fd stock? Who is selling Neuberger Berman High Yield Strateges Fd stock?
Who bought Neuberger Berman High Yield Strateges Fd stock? Who is buying Neuberger Berman High Yield Strateges Fd stock?
How do I buy Neuberger Berman High Yield Strateges Fd stock?
Shares of Neuberger Berman High Yield Strateges Fd can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Neuberger Berman High Yield Strateges Fd's stock price today?
One share of Neuberger Berman High Yield Strateges Fd stock can currently be purchased for approximately $11.71.
How big of a company is Neuberger Berman High Yield Strateges Fd?
Neuberger Berman High Yield Strateges Fd has a market capitalization of $231.79 million.
How can I contact Neuberger Berman High Yield Strateges Fd?
Neuberger Berman High Yield Strateges Fd's mailing address is 605 3rd Ave Frnt 2, NEW YORK, NY 10158-0180, United States. The investment management company can be reached via phone at +1-212-4768800.
MarketBeat Community Rating for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS)MarketBeat's community ratings are surveys of what our community members think about Neuberger Berman High Yield Strateges Fd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
Analysts' Ratings History for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN:NHS)
|Payout Ratio:||24.46% (Trailing 12 Months of Earnings) |
Dividend History by Quarter for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS)
Insider Trades by Quarter for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/10/2017||Thomas P Oreilly||Insider||Sell||4,000||$11.83||$47,320.00|| |
|8/9/2017||Thomas P Oreilly||Insider||Sell||14,000||$12.08||$169,120.00|| |
|12/23/2016||Thomas P Oreilly||Insider||Sell||10,000||$11.61||$116,100.00|| |
|12/21/2015||Bradley Tank||insider||Buy||28,000||$9.36||$262,080.00|| |
|8/25/2015||Bradley Tank||insider||Buy||28,900||$11.71||$338,419.00|| |
|7/14/2015||Thomas P Oreilly||Portfolio Manager||Buy||15,000||$11.57||$173,550.00|| |
|9/19/2013||Thomas P Oreilly||Portfolio Manager||Buy||10,000||$13.11||$131,100.00|| |
|7/17/2013||Thomas P Oreilly||Portfolio Manager||Buy||8,000||$13.00||$104,000.00|| |
|6/6/2013||Thomas P Oreilly||Portfolio Manager||Buy||10,000||$13.35||$133,500.00|| |
|5/9/2013||Ann H Benjamin||Portfolio Manager||Buy||17,395||$14.35||$249,618.25|| |
|11/19/2012||Thomas P Oreilly||Portfolio Manager||Buy||3,120||$13.01||$40,591.20|| |
|11/15/2012||Thomas P Oreilly||Portfolio Manager||Buy||3,120||$13.01||$40,591.20|| |
Latest Headlines for Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS)
No headlines for this company have been tracked by MarketBeat.com
Neuberger Berman High Yield Strateges Fd (NYSEAMERICAN NHS) Chart for Sunday, November, 19, 2017